Investing
180 Articles
In a new report, UBS updates its list of quality growth at a reasonable price, or Q-GARP, stocks as they…
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. on Monday, October 6, 2014.
The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have…
These are the top analyst upgrades and downgrades from 24/7 Wall St. for Wednesday, September 3, 2014.
Jon OggStocks turned green on Friday morning on hopes out of Russia, but the markets have remained at risk. Now…
These are this Friday's top analyst upgrades, downgrades and initiations from Wall Street firms on Friday, July 25, 2015. They…
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Wednesday, July 23, 2014. They include…
Add one more to the litany of pharmaceutical company mergers that are being made to avoid U.S. taxes. Mylan's existing…
Mylan reported first-quarter 2014 results before markets opened Thursday. The generic drug maker reaffirmed its full-year EPS guidance and hinted…
Shares of Mylan retreated first thing Monday morning, after the generic drugmaker's sweetened bid for Swedish drugmaker Meda was rejected.
In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off…
In a new report, RBC has a list of stocks with some of the largest percentage drops and the lowest…
Teva Pharmaceutical shares reached a new multiyear high Monday after the U.S. Supreme Court agreed to hear its appeal to…
Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large…
Two analyst upgrades on Friday, a new CEO and a 33% increase in its stock price since November may be…
Our top personal finance-related articles today. Your wallet will thank you later.